Skip to main content
Log in

Molecular studies in pediatric medulloblastomas

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Ten pediatric medulloblastoma patients were analyzed for DNA content, cell cycle, expression of drug resistance, apoptosis, cell proliferation, andN-myc genes to determine their prognostic significance. Medulloblastoma patients with progressive disease had fourth ventricle foraminal extension and larger tumors in the imaging studies. Patients with aneuploid tumors responded well to treatment regimens as compared with those with diploid tumors. Cell cycle analysis showed that the patients with progressive disease had a high S-phase fraction in the tumor cell population as compared with patients with favorable response to treatment. The correlation coefficients betweenBcl-2 andMRP, Bcl-2 andBax, p53 andp21, as well asKi67 andPCNA were positive and significant, indicating their possible coregulated expression. The relationship between these markers indicates their relative and cumulative effect on cellular drug resistance, apoptosis, and/or cell proliferation in pediatric medulloblastomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Friedman HS, Oakes WJ, Bigner SH, et al (1991) Medulloblastoma: tumor biological and clinical perspectives. J Neurooncol 11:1–15

    Article  PubMed  CAS  Google Scholar 

  2. Walker RW, Rosenbum MK (1992) Childhood medulloblastoma. Rev Neurol (Paris) 148:467–476

    CAS  Google Scholar 

  3. Provias JP, Becker LE (1996) Cellular and molecular pathology of medulloblastoma. J Neurooncol 29:35–43

    Article  PubMed  CAS  Google Scholar 

  4. Cushing H (1930) Experiences with the cerebellar medulloblastomas: a critical review. Acta Pathol Microbiol Scand 7:1–86

    Article  Google Scholar 

  5. Trojanowski JQ, Fung K-M, Rorke LB, et al (1994) In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood. Mol Chem Neuropathol 21:219–239

    PubMed  CAS  Google Scholar 

  6. Schiffer D, Cavalla P, Chio A, et al (1994) Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol (Berl) 87:362–370

    Article  CAS  Google Scholar 

  7. Jay V, Parkinson D, Becker L, et al (1994) Cell kinetic analysis in pediatric brain and spinal tumors: a study of 117 cases with Ki67 quantitation and flow cytometry. Pediatr Pathol 14:253–276

    PubMed  CAS  Google Scholar 

  8. Chou PM, Reyes-Mugica M, Barquin N, et al (1995) Multidrug resistance gene expression in childhood medulloblastoma: correlation with clinical outcome and DNA ploidy in 29 patients. Pediatr Neurosurg 23:283–292

    PubMed  CAS  Google Scholar 

  9. Rouah E, Wilson DR, Armstrong DL, et al (1989) N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system. Cancer Res 49:1797–1801

    PubMed  CAS  Google Scholar 

  10. Bandiali M, Pession A, Basso G, et al (1991) N-myc and C-myc oncogene amplification in medulloblastomas: evidence of particularly aggressive behavior of a tumor with C-myc amplification. Tumori 77:118–121

    Google Scholar 

  11. Tomilson FH, Jenkins RB, Scheithauer BW, et al (1994) Aggressive medulloblastoma with high level N-myc amplification. Mayo Clin Proc 69:359–365

    Google Scholar 

  12. Ramachandran C, Melnick SJ, Escalon E, et al (2000) Expression of apoptosis, cell proliferation and drug resistance in pediatric Wilms' tumors. Anticancer Res 20:3759–3766

    PubMed  CAS  Google Scholar 

  13. Ramachandran C, Melnick SJ, Escalon E, et al (2001) Cytogenetic and molecular characterization of a congenital mesoblastic nephroma. Pediatr Develop Pathol 4:402–411

    Article  CAS  Google Scholar 

  14. Ramachandran C, Mead D, Wellham LL, et al (1995) Expression of drug resistance-associated mdr-1, GST π and topoisomerase II genes during cell cycle traverse. Biochem Pharmacol 49:545–552

    Article  PubMed  CAS  Google Scholar 

  15. Ramachandran C, Kunikane H, You W, et al (1998) Phorbol ester-induced P-glycoprotein phosphorylation and functionality in the HTB-123 human breast cancer cell line. Biochem Pharmacol 56:709–718

    Article  PubMed  CAS  Google Scholar 

  16. Gajjar A, Heideman RL, Douglass EC, et al (1993) Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol 6:1212–1216

    Google Scholar 

  17. Zerbini C, Gelber RD, Weinberg D, et al (1993) Prognostic factors in medulloblastoma, including DNA ploidy. J Clin Oncol 4:616–622

    Google Scholar 

  18. Meyer JS, Marchosky A, Hickey WF (1993) Cell kinetic classification of tumors of the nervous system by DNA precursor labeling in vitro. Hum Pathol 24:1357–1364

    Article  PubMed  CAS  Google Scholar 

  19. Yasue M, Tomita T, Engelhard H, et al (1989) Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 70:385–391

    Article  PubMed  CAS  Google Scholar 

  20. Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151–157

    PubMed  CAS  Google Scholar 

  21. Walton MI, Whyson D, O'Connor PM, et al (1993) Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res 53:1853–1861

    PubMed  CAS  Google Scholar 

  22. Grant CE, Valdimarsson G, Hipfner DR, et al (1994) Over-expression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54:357–361

    PubMed  CAS  Google Scholar 

  23. Loe DW, Deeley RG, Cole SPC (1996) Biology of the Multidrug Resistance-associated Protein. MRP Eur J Cancer 32A:945–957

    Article  CAS  Google Scholar 

  24. Nunez G, Clarke MF (1994) The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol 4:399–403

    Article  PubMed  CAS  Google Scholar 

  25. Hara A, Hirose Y, Yoshimi N, et al (1997) Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Neurol Res 19:623–628

    PubMed  CAS  Google Scholar 

  26. Oltivai ZN, Milliman CL, Korsemeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609–616

    Article  Google Scholar 

  27. Canman CE, Kastan MB (1997) Role of p53 in apoptosis. Adv Pharmacol 41:429–460

    Article  PubMed  CAS  Google Scholar 

  28. El-Deiry WS, Tokino T, Velculescu VE, et al (1993) Wafl, a potential mediator of p53 tumor suppressor. Cell 75:817–825

    Article  PubMed  CAS  Google Scholar 

  29. Gerdes J, Lemke H, Baisch H, et al (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki67. J Immunol 133:1710–1715

    PubMed  CAS  Google Scholar 

  30. Scott RJ, Hall PA, Haldane JS, et al (1991) A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165:173–178

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cheppail Ramachandran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramachandran, C., Khatib, Z., Escalon, E. et al. Molecular studies in pediatric medulloblastomas. Brain Tumor Pathol 19, 15–22 (2002). https://doi.org/10.1007/BF02482451

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02482451

Key words

Navigation